Partner Event: 24th Edition Strategic Project & Portfolio Management for Pharma Conference

Optimising tools and processes to drive PPM efficiency and steer high efficiency projects

The marcus evans 24^th Edition Strategic Project & Portfolio Management for Pharma conference taking place on 17-19 January, 2024 in Frankfurt, Germany, will bring together leading project and portfolio managers to discuss how they’re supporting critical decision-making capabilities through implementing  the  best  methodologies, technologies, and organizational models. The event will explore how you can maximize the value  and  resilience  of  your  portfolio  through the  best  practices  in  project prioritization  and  resource  allocation, focusing  on  creating  the  ideal  balance  between  risks  and  opportunities. All these topics and more will be discussed in an open and engaging environment, with plenty of networking and brainstorming during the interactive sessions. At the end you’ll walk away with actionable insights on how to build effective management capabilities and navigate critical decisions.

Attending This Premier marcusevans Conference Will Enable You to:

• Unlock the power of AI in project management
• Build a fully integrated portfolio management system to maximise value creation in real time
• Leverage PPM reporting and drive transparency across the organisation
• Drive PMO efficiency to steer high efficiency projects
• Manage PPM for clinical trials and specialised therapeutics
• Optimise risk return profile and overall value of the global drug pipeline

Best Practices and Case Studies from:

• Paul Shaw, Vice President, EPMO, Sosei Heptares, UK
• Michael Collins, Executive Director Research, Development and Device Project Management, CSL Behring, Switzerland
• Gilles Brackman, Vice President of R&D, Flen Health, Belgium
• Maciej Szymaszek, Senior Director, Global Portfolio & Project Management, AstraZeneca, Sweden
• Gitana Vaičiulytė, PMO, Transformation Program Manager, Terumo Europe, Belgium
• Kamil Mroz, Director, Gene Therapy Program Management Lead (EPVM), UCB, Belgium

PIPMG members are entitled to €200 discount! For more information please contact: Ria Kiayia, Digital Media and PR Marketing Executive at riak@marcusevanscy.com or visit: https://bit.ly/3Pk3Kv1